Insider Transactions Reported by 20 Insiders of Olema Pharmaceuticals, Inc.

Symbol
OLMA on Nasdaq
Location
San Francisco, CA

Insiders trading volume in the past year

Olema Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paradigm Biocapital Advisors LP 10%+ Owner $173,767,954 01 Aug 2024
Bain Capital Life Sciences Investors, LLC 10%+ Owner $24,758,970 +$1,727,370 +7.5% 08 Jan 2025
Cyrus Harmon Director $24,438,946 -$287,036 -1.2% 22 Dec 2025
David C. Myles Ch. Discov. & Non Clin Dev Off $19,620,082 -$1,553,544 -7.3% 19 Dec 2025
Shane Kovacs Ch. Operating & Financial Off. $6,848,597 08 Dec 2025
Sean Bohen President and CEO, Director $6,682,718 26 Dec 2025
Graham G. Walmsley Director $5,724,000 11 Jun 2025
BVF PARTNERS L P/IL Director, Other* $3,716,633 11 Jun 2025
ANDREW RAPPAPORT Director $3,392,632 21 Nov 2025
Naseem Zojwalla Chief Medical Officer $124,138 -$7,530,148 -98% 19 Dec 2025
Kinney Horn Chief Business Officer $17,255 01 Feb 2023
IAN T. CLARK Director $0 -$7,873,109 -100% 19 Dec 2025
J. Scott Garland Director 11 Jun 2025
Sandra Horning Director 11 Jun 2025
Gorjan Hrustanovic Director 11 Jun 2025
Peter J. Kushner Chief Scientific Officer 01 Feb 2022
Yi Larson Director 11 Jun 2025
Shawnte Mitchell Chief Legal Officer 28 Feb 2025
John B. Moriarty EVP, Ch. Legal Officer & Sec. 01 Feb 2023
CYNTHIA M. BUTITTA Director 11 Jun 2025

Recent Insider Transactions by Companies or Individuals for Olema Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.